.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer in 2014 for a mons...
.On the heels of a phase 3 succeed that stopped working to excite clients, Ironwood Pharmaceuticals ...
.Don't quit Monte Rosa Therapies currently. The Boston-based biotech is actually enjoying after sign...
.Accept to today's Chutes & Ladders, our roundup of notable leadership hirings, shootings and ret...
.Commemorating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey F...
.AbbVie has actually come back to the source of its antipsychotic giant Vraylar looking for another ...
.GenSight Biologics is full weeks off of lacking funds. Once more. The biotech only possesses enough...
.Monopar Therapeutics is actually bouncing back a medicine coming from the dump of AstraZeneca's rar...
.Along with brand-new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one team ...
.After forming a gene treatment partnership with Dyno Therapeutics in 2020, Roche is back for more.I...